Ciurea A, Papagiannoulis E, Bürki K, et al. - This study was attempted to explore if the transient reduction in rheumatology services imposed by virus containment measures during the COVID-19 pandemic was correlated with disease worsening in axial spondyloarthritis (axSpA), rheumatoid arthritis (RA), or psoriatic arthritis (PsA). Researchers compared patient-reported disease activity assessed during face-to-face visits and/or via a smartphone application between three periods of each 2 months duration (before, during, and after the COVID-19-wave) from January to June 2020 in 666 patients with axSpA, RA, and PsA in the Swiss Clinical Quality Management cohort. This study's findings demonstrate that a short interruption of in-person patient–rheumatologist interactions had no major detrimental effect on the disease course of axSpA, RA, and PsA as evaluated by patient-reported outcomes.